Why Value Analysis Struggles to Scale Without Better Data - And Why That's an Opportunity

Value Analysis (VA) teams sit at the centre of some of healthcare's most important decisions, balancing clinical quality, financial stewardship, and operational consistency. Across health systems, VA committees are deeply engaged, highly collaborative, and committed to doing the right thing.

Yet many leaders still voice a familiar tension: “Our Value Analysis committee is doing strong work, but it's getting harder to keep up with the pace and complexity of decisions.”

This isn't a reflection of effort or governance. It's a reflection of how much healthcare data has grown, and how fragmented it remains. As spend categories become more complex and decision velocity increases, Value Analysis is being asked to operate at a scale it was never originally designed for.

The Structural Reality of Value Analysis Committees

Traditional VA committees were built for a different era. Most are designed to review products and proposals episodically, evaluate decisions using historical snapshots, and rely on consensus-building during scheduled meetings. This approach works well when decisions are infrequent, data is relatively static, and variation is easy to identify. Today's reality looks very different, especially in high-cost, high-variation categories like implants and physician preference items.

The natural tension that emerges

• VA becomes more reactive than leaders would like
• Time is spent aligning on what the data says rather than what action to take
• Insights arrive after utilisation patterns have already shifted

This isn't a failure of governance. It's a scale challenge driven by fragmented data and lagging visibility.

Manual Data Aggregation: A Structural Bottleneck, Not a Skill Gap

Behind most VA meetings is a familiar process: pulling data from multiple systems, reconciling usage, pricing, and contracts, translating clinical activity into financial context, and building spreadsheets and slides just in time. This work is thoughtful, detailed, and necessary, but it creates unavoidable constraints.

What fragmentation introduces

• Data is retrospective by nature: By the time information is assembled, it reflects what already happened, not what's unfolding now.
• Insights are episodic: Analysis occurs at meeting cadence, not at the pace of clinical activity.
• Scaling becomes harder, not easier: As facilities, physicians, and products grow, effort increases faster than clarity.

VA professionals bring deep judgment and experience. Fragmented data forces them to spend time assembling context instead of applying insight.

Lagging Insights Limit Momentum

When insights arrive late, pricing variation is identified after spend occurs, exceptions are reviewed individually instead of pattern-based, and standardisation conversations start on the back foot. This can unintentionally shift VA into a defensive posture, responding to outcomes rather than shaping them. Again, this isn't about capability or commitment. It's about timing and data flow.

The Reframe: Value Analysis Thrives with Connected Intelligence

As healthcare complexity increases, the question isn't how to make VA work harder. It's how to connect intelligence across systems, teams, and moments of decision. Instead of asking “How do we tighten governance?” or “How do we add more review steps?” leading organisations are asking: Is our data structured, timely, and connected enough to support how Value Analysis operates today?

Data readiness means

• Case-level insight, not just aggregated summaries
• Continuous visibility instead of manual compilation
• Signals that surface early, before patterns are entrenched

When intelligence is connected, governance becomes lighter, not heavier. Committees focus on judgment, alignment, and trade-offs. Decisions move faster with greater confidence.

What Scalable Value Analysis Looks Like in Practice

Organisations that successfully scale VA tend to share common traits: always-on visibility into utilisation, pricing, and variation; early signals that guide conversations proactively; exception-based focus that respects clinical nuance; and a shared language across clinical, supply chain, and finance teams. In these environments, Value Analysis becomes more strategic, more trusted, and more impactful without increasing workload.

What Leaders Can Take Away

For supply chain and value analysis leaders, progress doesn't come from adding pressure. It comes from improving connection. Consider: How much time is spent preparing data vs. discussing decisions? Do insights arrive early enough to influence behaviour? Can variation be explained clearly across teams? Is VA being asked to scale without a connected data foundation?

Final Thought

Value Analysis teams are already doing the hard work of alignment. As healthcare data continues to fragment across systems and workflows, the next evolution of VA is about Connected Intelligence, bringing the right insight, to the right people, at the right time. When data catches up to the complexity of care, Value Analysis doesn't just scale. It leads.